Literature DB >> 9389839

Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care.

P H Martin1, B V Murthy, A J Petros.   

Abstract

We have studied prospectively, in nine children requiring sedation to facilitate mechanical ventilation, the metabolic, biochemical and haemodynamic effects of infusion of propofol. Children were given infusions of propofol 1-4mg kg-1 h-1 and fentanyl 1-5 micrograms kg-1 h-1 for 48 h. Heart rate, arterial pressure, central venous pressure, fluid balance and urine output were recorded hourly and sedation scores every 4 h. In addition to routine haemodynamic and biochemical measurements in the intensive care, 6-hourly arterial blood-gas analysis and 12-hourly measurements of serum concentrations of glucose, lactate and electrolytes, renal function, triglycerides and liver function tests were performed. Urine was analysed for ketones. There were no significant differences in haemodynamic or biochemical variables during the 48-h period. In this small sample of children, propofol combined with fentanyl provided excellent sedation with no evidence of cardiac, renal or hepatic impairment. Under these very proscriptive conditions we did not encounter lipaemia or acidosis with infusion of propofol. Thus propofol may be a safe sedative agent for use in paediatric intensive care if used appropriately. Further large scale studies are needed to determine if warnings against the use of this agent in paediatric intensive care units are justified.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389839     DOI: 10.1093/bja/79.3.276

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Propofol infusion syndrome.

Authors:  Michael Philip Burke; Barry Dixon; Kenneth Opeskin
Journal:  Forensic Sci Med Pathol       Date:  2006-12       Impact factor: 2.007

2.  Adherence to a Pediatric Continuous Infusion Propofol Policy for Sedation in Mechanically Ventilated Patients: Opportunities for Change and Improvement.

Authors:  Ashley M Martin; Andrea Tribuzi; Maggie L Schieber; Pamela D Reiter
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

Review 3.  [Propofol infusion syndrome].

Authors:  J Motsch; J Roggenbach
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

4.  Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery.

Authors:  Catherijne A J Knibbe; Gitte Melenhorst-de Jong; Maaike Mestrom; Carin M A Rademaker; Allart F A Reijnvaan; Klaas P Zuideveld; Paul F M Kuks; Hans van Vught; Meindert Danhof
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.